Dexamethasonum

Hazard statements (CLP)

H361d, H373

Code

Statements

H361d

Suspected of damaging the unborn child

SECTION 2: Hazards identification

Regulation (EC) No. 1272/2008 Classification of the substance or mixture

Hazard statements

H361d Suspected of damaging the unborn child. H373 May cause damage to organs through prolonged or repeated exposure. H361d Suspected of damaging the unborn child. H373 May cause damage to organs through prolonged or repeated exposure.

Precautionary statements

P201 Obtain special instructions before use. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/face protection. P308+P313 IF expsoed or concerned: Get medicinal advice/attention. P405 Store locked up. P501.3 Disposal in compliance with local and national regulations. P201 Obtain special instructions before use. P260 Do not breathe dust/fume/gas/mist/vapours/spray. P280 Wear protective gloves/protective clothing/eye protection/face protection. P308+P313 IF expsoed or concerned: Get medicinal advice/attention. P405 Store locked up. P501.3 Disposal in compliance with local and national regulations.

Contains

Dexamethasone Reduced labeling (<= 125 ml)

2.3 Other hazards

The Substance does not meet PBT-criteria. This substance does not meet the vPvB-criteria. This substance does not have endocrine disrupting properties with respect to humans. This substance does not have endocrine disrupting properties with respect to non-target organisms.

2.1 Classification of the substance or mixture

Classification (Regulation (EC) No. 1272/2008) Repr. 2 H361d STOT RE 2 H373 The product is classified and labelled in accordance with Regulation (EC) No 1272/2008 For explanation of abbreviations see section 16. 2.2. Label elements